<DOC>
	<DOCNO>NCT01566591</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety H1-Coil deep brain rTMS subject bipolar depression , take mood stabilizer previously unsuccessfully treat antidepressant medication .</brief_summary>
	<brief_title>Safety Efficacy Study Deep Transcranial Magnetic Stimulation Bipolar Depression</brief_title>
	<detailed_description>This multi center , randomize , double blind study evaluate efficacy safety H1-Coil deep brain rTMS subject bipolar depression , take mood stabilizer previously unsuccessfully treat antidepressant medication . The study design period 8 week 3 week subject taper medication treat 5 week . Two follow visit perform week 6 8 last TMS treatment . Mood mental status closely monitored standard psychological scale assessment</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Outpatients patient suffer episode bipolar depression ( BP1 BP2 ) accord DSM IV , additional requirement duration current episode ≥ 4 week CGI ≥ 4 . Men Women Ages 2268 year . Negative answer safety screen questionnaire transcranial magnetic stimulation . Taking mood stabilize medication ( e.g. , Lithium , Lamictal , Tegretol , Topamax , etc . ) therapeutic dose atypical antipsychotic medication prescribe mood stabilizer treat physician , except Leponex ( Clozapine ) . According treat physician patient compliant take moodstabilizing medication . patient suffer diagnosis axis 1 schizophrenia , suffer psychotic depression current episode . Diagnosed suffer Severe Borderline Personality Disorder hospitalize due exacerbation relate borderline personality disorder . Subjects suffer Severe Personality Disorder also exclude . Present suicidal risk assess investigator Patients bipolar cycle le 30 day . History epilepsy seizure ( EXCEPT therapeutically induce ECT ) history first degree relative . Increased risk seizure reason , include prior diagnosis increase intracranial pressure ( large infarction trauma ) , history significant head trauma loss consciousness great equal 5 minute . History head injury . History metal head ( outside mouth ) . Metallic particle eye , implanted cardiac pacemaker intracardiac line , implanted neurostimulators , intracranial implant ( e.g. , aneurysm clip , shunt , stimulators , cochlear implant , electrode ) implant medical pump . Hearing loss . Individuals significant neurological disorder insult include , limited : Any condition likely associate increase intracranial pressure Space occupy brain lesion History cerebrovascular accident Transient ischemic attack within two year Cerebral aneurysm Dementia Parkinson 's disease Huntington 's chorea Multiple sclerosis Current History substance abuse include alcoholism history substance abuse include alcoholism within past 6 month ( except nicotine caffeine ) . Inadequate communication patient . Under custodial care . Participation currently another clinical study enrol another clinical study within 30 day prior study . Participants suffer unstable physical disease high blood pressure acute , unstable cardiac disease Use fluoxetine within 6 week baseline visit Use Monoamine Oxidase Inhibitor ( MAOI ) within 2 week baseline visit Current use antidepressant medication course trial . Current use Leponex ( Clozapine ) . Previous treatment TMS Women breastfeed Known suspect pregnancy Women childbearing potential use medically accept form contraception engage sexual intercourse .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>68 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Bipolar Depression</keyword>
</DOC>